Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.

Autor: YEE, Y. K.1 (AUTHOR), CHEUNG, T. K.1 (AUTHOR), CHU, K.‐M.2 (AUTHOR), CHAN, C. K.1 (AUTHOR), FUNG, J.1 (AUTHOR), CHAN, P.1 (AUTHOR), BUT, D.1 (AUTHOR), HUNG, I.1 (AUTHOR), CHAN, A. O. O.1 (AUTHOR), YUEN, M. F.1 (AUTHOR), HSU, A.1 (AUTHOR), WONG, B. C. Y.1 (AUTHOR)
Zdroj: Alimentary Pharmacology & Therapeutics. Oct2007, Vol. 26 Issue 7, p1063-1067. 5p. 1 Diagram, 2 Charts.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje